Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granule in Triple Negative Breast Cancer
NCT02615457Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Oct 2015
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of huaier granule in triple-negative breast cancer (TNBC), sponsored by Shandong University. Status: unknown.
02
Drugs
huaier granule
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02615457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615457.